Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous
studies; however, a large portion of the genetic risk for this disease remains unexplained. …

We undertook a two-stage genome-wide association study (GWAS) of Alzheimer's disease (AD)
involving over 16,000 individuals, the most powerful AD GWAS to date. In stage 1 (3,941 …

The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association
study of late-onset Alzheimer disease using a three-stage design consisting of a discovery …

Amyloid precursor protein (APP) is endoproteolytically processed by BACE1 and γ-secretase
to release amyloid peptides (Aβ40 and 42) that aggregate to form senile plaques in the …

Mutations in the presenilin 1 (PS1) and presenilin 2 genes cosegregate with the majority of
early-onset familial Alzheimer's disease (FAD) pedigrees. We now document that the Aβ1–42…

Normal processing of the amyloid β protein precursor (βAPP) results in secretion of a soluble
4-kilodalton protein essentially identical to the amyloid β protein (Aβ) that forms insoluble …

The 4-kilodalton (39 to 43 amino acids) amyloid β protein (βAP), which is deposited as
amyloid in the brains of patients with Alzheimer's disease, is derived from a large protein, the …

The 4-kilodalton amyloid βprotein (Aβ), which forms fibrillar deposits in Alzheimer's disease (AD),
is derived from a large protein referred to as the amyloid β protein precursor (βAPP). …

Several pathogenic Alzheimer's disease (AD) mutations have been described, all of which
cause increased amyloid β-protein (Aβ) levels. Here we present studies of a pathogenic …

The accumulation of amyloid β protein (Aβ) in the Tg2576 mouse model of Alzheimer's disease
(AD) was evaluated by ELISA, immunoblotting, and immunocytochemistry. Changes in …